258 related articles for article (PubMed ID: 32408396)
1. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract][Full Text] [Related]
2. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
3. Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer.
Xia Q; Jin H; Zhang X; Yan W; Meng D; Ding B; Cao J; Li D; Wang S
Int Immunopharmacol; 2020 Nov; 88():106935. PubMed ID: 32889244
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of HPV-independent cervical cancers.
Banister CE; Liu C; Pirisi L; Creek KE; Buckhaults PJ
Oncotarget; 2017 Feb; 8(8):13375-13386. PubMed ID: 28077784
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract][Full Text] [Related]
7. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma.
Yang S; Yao B; Wu L; Liu Y; Liu K; Xu P; Zheng Y; Deng Y; Zhai Z; Wu Y; Li N; Zhang D; Kang H; Dai Z
Mol Ther Oncolytics; 2021 Jun; 21():207-219. PubMed ID: 34095460
[TBL] [Abstract][Full Text] [Related]
9. A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
Chen H; Li H; Wang L; Li Y; Yang C
J Obstet Gynaecol; 2022 Feb; 42(2):327-332. PubMed ID: 34082663
[TBL] [Abstract][Full Text] [Related]
10. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
Li C; Ke J; Liu J; Su J
J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
[TBL] [Abstract][Full Text] [Related]
12. Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
Li X; Cai Y
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445744
[TBL] [Abstract][Full Text] [Related]
13. HPV-Related Promoter Methylation-Based Gene Signature Predicts Clinical Prognosis of Patients With Cervical Cancer.
Zhou R; Chen Z; Xiao ZR; Wang SL; Rong C
Front Oncol; 2021; 11():753102. PubMed ID: 34745985
[TBL] [Abstract][Full Text] [Related]
14. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes and pathways for risk stratification in HPV-associated cancers governing different anatomical sites.
Kwon EJ; Lee HR; Lee JH; Seo C; Ha M; Roh J; Kim YH; Jang JY
Front Biosci (Landmark Ed); 2022 Jan; 27(1):2. PubMed ID: 35090306
[TBL] [Abstract][Full Text] [Related]
17. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
[TBL] [Abstract][Full Text] [Related]
18. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W
Gene; 2020 Jan; 723():144142. PubMed ID: 31589957
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix: human papillomavirus genotype and methylation status and immunohistochemical study.
Kawakami F; Semba S; Itami H; Oka N; Sudo T; Ebina Y; Ohbayashi C; Mikami Y; Yokozaki H; Itoh T
Kobe J Med Sci; 2014 Nov; 60(3):E66-73. PubMed ID: 25612672
[TBL] [Abstract][Full Text] [Related]
20. Independent prognostic role of human papillomavirus genotype in cervical cancer.
Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
